Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Withdrawn × Lidocaine × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Terminated 3 Recruiting 3 Completed 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1

Interventions

pembrolizumab 50 Radiotherapy 46 Cisplatin 39 Paclitaxel 37 Gemcitabine 35 Cyclophosphamide 34 Carboplatin 34 Dexamethasone 31 Nivolumab 30 Fluorouracil 29 Docetaxel 29 Bevacizumab 28 Oxaliplatin 26 durvalumab 23 Leucovorin 23 Rituximab 22 Magnetic Resonance Spectroscopy 22 Capecitabine 20 Pemetrexed 19 Drug Therapy 18 atezolizumab 17 Radiosurgery 17 Cytarabine 17 Radiation 16 Doxorubicin 16 Bortezomib 16 Prednisone 15 Etoposide 14 fludarabine 13 Lenalidomide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00321347 2012-06-22

Intravenous (IV) Lidocaine for Opioid-refractory Pain

San Diego Hospice & Palliative Care

Phase 2 Withdrawn

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡